Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Phase 4

Completed

• Conditions: Substance-Related Disorders; Cocaine-Related Disorders

• Registration Number: NCT00015301
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Detailed Description

The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Study Timeline

• Study First Submitted QC: 2001-04-17
• Study First Submitted: 2001-04-18
• Study First Posted: 2001-04-18
• Status Verified: 2002-12
• Study Start: 2003-12
• Primary Completion: 2005-06
• Study Completion: 2005-08
• Last Update Submitted: 2017-02-23
• Last Update Posted: 2017-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Healthy normals

Exclusion Criteria

History of head trauma or loss of consciousness. Significant medical history. History of seizures.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dopamine receptor availability

Trial Locations

Locations (1)

New York MDRU; 🇺🇸 New York, New York, United States